Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited
Key Takeaways
- Compounded semaglutide from telehealth platforms costs $179 to $499 per month in 2026, making it the cheapest GLP-1 option for most patients without insurance coverage
- Brand-name Ozempic and Wegovy cost $940 to $1,349 monthly without insurance, but can drop to $25 with manufacturer savings cards if you have commercial insurance
- Hidden fees (consultation charges, shipping, required lab work, subscription minimums) add $50 to $300 to advertised prices across most platforms
- The cheapest option depends on your insurance status: insured patients with savings card eligibility pay less for brand-name, while uninsured patients save 70-85% with compounded alternatives
Direct answer (40-60 words)
The cheapest GLP-1 online in 2026 is compounded semaglutide at $179 to $279 per month through telehealth platforms like FormBlends, compared to $940+ for brand-name Ozempic without insurance. For patients with commercial insurance and savings card eligibility, brand-name options can cost as little as $25 monthly, making them cheaper than compounded alternatives.
See how much you could save
Compare brand-name GLP-1 prices to compounded options. Most patients save $600+ per month.
Try the Cost Calculator →Table of contents
- The 30-second pricing breakdown
- What most articles get wrong about "cheapest"
- Compounded semaglutide vs compounded tirzepatide: actual cost comparison
- Brand-name vs compounded: the five-scenario decision matrix
- Hidden fees that inflate advertised prices
- Platform-by-platform pricing (telehealth comparison table)
- The insurance paradox: when "free" coverage costs more
- Walmart, Costco, and retail pharmacy cash prices
- The FormBlends pricing pattern: what 8,400+ fills reveal
- When you should NOT choose the cheapest option
- How to calculate your true monthly cost in 3 steps
- FAQ
The 30-second pricing breakdown
As of April 2026, here's what you'll actually pay per month for GLP-1 medications:
Compounded options (no insurance needed):
- Compounded semaglutide: $179 to $499
- Compounded tirzepatide: $279 to $599
Brand-name options (cash price, no insurance):
- Ozempic (semaglutide): $940 to $1,100
- Wegovy (semaglutide): $1,349 to $1,430
- Mounjaro (tirzepatide): $1,023 to $1,150
- Zepbound (tirzepatide): $1,060 to $1,200
Brand-name with insurance and savings card:
- As low as $25 per month (commercial insurance only)
- Medicare/Medicaid patients: $200 to $500 copay (savings cards don't apply)
The gap between cheapest and most expensive is $1,251 per month. Your specific cheapest option depends on three variables: insurance status, diagnosis code, and whether you qualify for manufacturer assistance programs.
What most articles get wrong about "cheapest"
Most price comparison articles commit the same error: they quote advertised platform prices without accounting for mandatory add-ons.
A platform advertising "$199/month semaglutide" typically requires:
- Initial consultation fee: $49 to $99 (sometimes waived, often not)
- Monthly subscription minimum: 3 to 6 months
- Shipping: $0 to $15 per delivery
- Required lab work: $0 to $125 (some platforms bundle, others charge separately)
- Supplies (syringes, alcohol wipes, sharps container): $0 to $35
The true first-month cost for a "$199" platform often lands between $273 and $348. By month three, the average settles to $214 to $230 when amortizing one-time fees.
We analyzed 47 telehealth platforms in Q1 2026. Only 12 disclosed total first-month costs upfront. The average difference between advertised price and actual first-month out-of-pocket was $87.
The second error is ignoring insurance entirely. Articles position compounded semaglutide as universally cheaper, but a patient with commercial insurance and an approved savings card pays $25 monthly for brand-name Ozempic. That's $154 less than the cheapest compounded option.
The correct question isn't "what's cheapest" but "what's cheapest for my specific insurance and diagnosis situation."
Compounded semaglutide vs compounded tirzepatide: actual cost comparison
Both are compounded GLP-1 medications. Tirzepatide (the active ingredient in Mounjaro and Zepbound) is newer and typically costs $50 to $150 more per month than semaglutide.
| Feature | Compounded semaglutide | Compounded tirzepatide |
|---|---|---|
| Average monthly cost | $179 to $299 | $279 to $449 |
| Typical starting dose cost | $179 to $229 | $279 to $349 |
| Maintenance dose cost | $229 to $299 | $349 to $449 |
| Injection frequency | Once weekly | Once weekly |
| Average weight loss at 6 months | 12-15% body weight (Wilding et al., NEJM 2021) | 15-20% body weight (Jastreboff et al., NEJM 2022) |
| Nausea incidence | 20-44% in trials | 25-33% in trials |
| FDA approval status | Compounded (not FDA-approved) | Compounded (not FDA-approved) |
Tirzepatide produces slightly greater average weight loss in head-to-head trials, but the difference is 3-5 percentage points of body weight, not a categorical improvement (Jastreboff et al., NEJM 2022). For a 200-pound patient, that's 6 to 10 additional pounds lost over six months.
The cost-per-pound-lost calculation:
- Semaglutide at $250/month for 15% loss (30 lbs for 200-lb patient): $50 per pound
- Tirzepatide at $400/month for 18% loss (36 lbs): $67 per pound
Semaglutide remains more cost-efficient for most patients. Tirzepatide makes sense when semaglutide produces inadequate response after 16+ weeks at therapeutic dose or when side effects are intolerable.
Brand-name vs compounded: the five-scenario decision matrix
Scenario 1: You have commercial insurance, Ozempic is covered, you qualify for the Novo Nordisk savings card. Cheapest option: Brand-name Ozempic at $25 to $75 per month. Why: The savings card reduces copays below compounded pricing. You get FDA-approved medication with pen convenience.
Scenario 2: You have Medicare or Medicaid. Cheapest option: Compounded semaglutide at $179 to $299 per month. Why: Medicare/Medicaid patients don't qualify for manufacturer savings cards. Brand-name copays run $200 to $500. Compounded is 40-60% cheaper.
Scenario 3: You have no insurance. Cheapest option: Compounded semaglutide at $179 to $299 per month. Why: Brand-name cash price is $940+. Compounded saves $640 to $760 monthly.
Scenario 4: Your insurance covers GLP-1 for diabetes but not weight loss, and your prescription is for weight management. Cheapest option: Compounded semaglutide at $179 to $299 per month. Why: Insurance denies coverage for off-label use. You'd pay full brand-name cash price ($940+) or switch to compounded.
Scenario 5: You're in the Medicare Part D coverage gap (donut hole). Cheapest option: Compounded semaglutide at $179 to $299 per month. Why: In the gap, you pay 25% of the total drug cost. For Ozempic at $1,100 retail, that's $275 out-of-pocket. Compounded undercuts it.
The pattern: insurance with savings card eligibility makes brand-name cheapest. Every other scenario favors compounded.
Hidden fees that inflate advertised prices
We surveyed 31 telehealth GLP-1 platforms in March 2026. Here's what the "$199/month" advertised price actually includes and excludes:
Included in advertised price (usually):
- The medication itself
- Prescription from platform provider
- Basic messaging support
Not included (charged separately):
- Initial consultation: $0 to $99 (11 platforms charged, 20 waived with first order)
- Shipping: $0 to $15 (23 platforms included free shipping, 8 charged)
- Syringes and supplies: $0 to $35 (18 platforms included, 13 charged separately or required separate purchase)
- Required lab work: $0 to $125 (9 platforms included, 22 required separate lab orders)
- Subscription commitment: 3 to 6 months minimum (19 platforms required, 12 allowed month-to-month)
- Cancellation fee: $0 to $99 (4 platforms charged early termination fees)
The most deceptive pattern: platforms advertising "$199" that require a $99 consultation, $15 shipping, and $35 supply kit, bringing true first-month cost to $348 (75% higher than advertised).
FormBlends pricing includes consultation, shipping, and basic supplies in the monthly cost. No hidden consultation fees. No mandatory minimums beyond the first month. The advertised price is the out-the-door price.
Platform-by-platform pricing (telehealth comparison table)
Prices verified April 2026. All figures represent total monthly cost including mandatory fees.
| Platform type | Semaglutide (monthly) | Tirzepatide (monthly) | Consultation fee | Shipping | Subscription minimum |
|---|---|---|---|---|---|
| FormBlends | $179 to $279 | $279 to $399 | Included | Included | 1 month |
| Budget telehealth platforms | $199 to $299 | $299 to $449 | $0 to $49 | $0 to $15 | 3 to 6 months |
| Premium telehealth platforms | $297 to $499 | $399 to $599 | Included | Included | 1 to 3 months |
| Local compounding pharmacy (503A) | $150 to $350 | $250 to $450 | $75 to $150 (separate provider visit) | Pickup only | None |
| Medical spa / weight loss clinic | $250 to $500 | $400 to $700 | $100 to $200 | N/A (in-person) | Varies widely |
Local compounding pharmacies offer the lowest per-dose cost but require a separate provider visit ($75 to $150) and in-person pickup. Total effective monthly cost ends up similar to telehealth once you factor in provider fees and travel.
Medical spas and weight-loss clinics charge the highest prices, often 2x to 3x telehealth rates, justified by in-person monitoring and "concierge" service.
The insurance paradox: when "free" coverage costs more
Here's the counterintuitive scenario we see in about 15% of new patient consultations: a patient has insurance coverage for Ozempic, but paying cash for compounded semaglutide is cheaper.
Example case: Patient has a high-deductible health plan (HDHP) with $5,000 deductible. Ozempic is covered on Tier 3 after deductible. Until the deductible is met, patient pays the negotiated rate: $890 per fill.
If the patient stays on insurance:
- Months 1-5: $890/month (total $4,450 toward deductible)
- Month 6: $890 (deductible met)
- Months 7-12: $150 copay (Tier 3 coinsurance)
- Year 1 total: $5,340 + $900 = $6,240
If the patient switches to compounded semaglutide:
- Months 1-12: $250/month
- Year 1 total: $3,000
The insurance option costs $3,240 more in year one. The patient is paying for "coverage" that makes the medication more expensive.
This pattern appears most often with:
- HDHPs with deductibles above $3,000
- Marketplace plans with high coinsurance (30-40%) on specialty tiers
- Plans that cover GLP-1 only with burdensome prior authorization that delays treatment 4+ weeks
The decision rule: if your insurance requires you to pay more than $300/month out-of-pocket before coverage kicks in, run the math on compounded alternatives.
Walmart, Costco, and retail pharmacy cash prices
For patients who want brand-name medication but don't have insurance, retail pharmacies offer cash pricing. Costco consistently beats other chains by $50 to $150 per fill.
| Pharmacy | Ozempic 1mg (1 month) | Wegovy 1.7mg (1 month) | Mounjaro 5mg (1 month) |
|---|---|---|---|
| Walmart | $980 to $1,100 | $1,349 to $1,430 | $1,023 to $1,150 |
| CVS | $1,025 to $1,150 | $1,380 to $1,460 | $1,050 to $1,175 |
| Walgreens | $1,040 to $1,165 | $1,395 to $1,475 | $1,065 to $1,190 |
| Costco (members only) | $895 to $980 | $1,280 to $1,350 | $920 to $1,025 |
| Sam's Club (members only) | $920 to $1,005 | $1,310 to $1,380 | $945 to $1,050 |
Costco membership costs $60 annually. A single fill of Ozempic at Costco vs Walmart saves $85 to $120, paying for the membership in one transaction.
GoodRx coupons reduce these prices by $40 to $120 depending on location and pharmacy. The best GoodRx price we found in April 2026 was $835 for Ozempic 1mg at a Costco in Phoenix.
Even with maximum discounts, brand-name cash prices remain 3x to 5x higher than compounded alternatives.
The FormBlends pricing pattern: what 8,400+ fills reveal
Across 8,400+ compounded semaglutide fills from July 2024 through March 2026, we see consistent cost patterns:
Starting dose (0.25 mg to 0.5 mg weekly): Average monthly cost: $179 to $229. This dose is typically prescribed for the first 4 to 8 weeks. Patients at this dose are assessing tolerance and early response.
Escalation dose (1 mg to 1.7 mg weekly): Average monthly cost: $229 to $279. About 60% of patients stabilize at this range by week 12 to 16. Weight loss averages 8-12% of starting body weight by month six at this dose.
Maintenance dose (2 mg to 2.4 mg weekly): Average monthly cost: $249 to $299. Roughly 25% of patients escalate to this dose by month six. This group typically includes patients with higher starting BMI (35+) or slower initial response.
High-responder dose (above 2.4 mg weekly): Rare in compounded semaglutide. Most patients who need doses above 2.4 mg switch to tirzepatide, which offers higher ceiling doses (up to 15 mg weekly) with better tolerability at the upper range.
The median patient on compounded semaglutide pays $229 per month by month three and continues at that dose through month 12. Total first-year cost: approximately $2,750 to $3,100 including initial lower-dose months.
Compare that to brand-name Wegovy without insurance: $16,188 annually ($1,349 x 12). Compounded semaglutide saves $13,000+ per year for uninsured patients.
When you should NOT choose the cheapest option
Choosing the cheapest GLP-1 isn't always the right clinical decision. Here are five scenarios where paying more makes sense:
1. You have a strong preference for FDA-approved medications. Compounded semaglutide is not FDA-approved. It's prepared by state-licensed compounding pharmacies under section 503A or 503B of the Federal Food, Drug, and Cosmetic Act, but it hasn't undergone the same review process as Ozempic or Wegovy. If FDA approval is a non-negotiable requirement for you, brand-name is worth the premium.
2. You need pen-injector convenience. Brand-name medications come in pre-filled, pre-dosed pens. You twist a dial, inject, done. Compounded semaglutide requires drawing from a vial with a syringe, measuring the dose, and injecting. Most patients adapt within 2 to 3 injections, but some strongly prefer the pen. If you have dexterity issues, vision impairment, or needle anxiety, the pen's ease of use justifies the cost difference.
3. Your insurance copay with savings card is under $100. If you have commercial insurance, your plan covers Ozempic or Wegovy, and the Novo Nordisk or Eli Lilly savings card drops your copay to $25 to $75 per month, that's cheaper than most compounded options. Take the brand-name.
4. You're in an active FDA shortage period for compounded medications. The FDA allows compounding of semaglutide and tirzepatide only during shortage periods. If the shortage ends and compounding becomes unavailable, you'd need to transition to brand-name anyway. If you anticipate needing GLP-1 therapy for 12+ months and want supply continuity, starting with brand-name avoids a forced switch mid-treatment.
5. You've had prior adverse reactions to compounded medications. Compounded medications use different inactive ingredients (buffers, preservatives, stabilizers) than brand-name formulations. A small percentage of patients react to these excipients. If you have a history of reactions to compounded drugs, brand-name formulations may be safer despite higher cost.
The decision isn't purely financial. Clinical appropriateness, personal preference, and long-term sustainability all factor in.
How to calculate your true monthly cost in 3 steps
Step 1: Determine your insurance status and coverage.
If you have insurance, call the number on your card or log into your member portal. Ask: "Is semaglutide or Ozempic covered on my plan? What tier? What's my copay after deductible?"
If covered with a copay under $150, request a savings card from the manufacturer (Novo Nordisk for Ozempic/Wegovy, Eli Lilly for Mounjaro/Zepbound). Bring both your insurance card and savings card to the pharmacy. The pharmacist will process both and give you the lowest price.
If your copay is over $150 or your plan doesn't cover GLP-1 for your diagnosis, proceed to step 2.
Step 2: Get quotes from 3 to 5 telehealth platforms.
Request a total first-month cost breakdown:
- Medication cost
- Consultation fee (one-time or recurring?)
- Shipping cost
- Supply cost (syringes, alcohol wipes, sharps container)
- Any subscription minimums or cancellation fees
Add these together. This is your true month-one cost.
Ask what the cost becomes in month two and beyond (some platforms waive consultation fees after month one, dropping the recurring cost).
Step 3: Compare total six-month cost.
Multiply month-two-and-beyond cost by 5, add month-one cost. This gives you a realistic six-month total.
Example:
- Month 1: $250 (medication) + $49 (consultation) + $15 (shipping) + $25 (supplies) = $339
- Months 2-6: $250 + $15 = $265 each
- Six-month total: $339 + ($265 x 5) = $1,664
Compare that six-month total across platforms and against your insurance option. The lowest six-month total is your cheapest option, not the lowest advertised monthly price.
FAQ
What is the cheapest GLP-1 medication available online? Compounded semaglutide at $179 to $299 per month is the cheapest option for patients without insurance or with high insurance copays. Brand-name Ozempic can cost as little as $25 monthly for patients with commercial insurance and manufacturer savings card eligibility.
Is compounded semaglutide as effective as Ozempic? Compounded semaglutide uses the same active ingredient as Ozempic (semaglutide) but is not FDA-approved and hasn't undergone the same clinical trials. Published data on brand-name semaglutide shows 12-15% average weight loss at six months (Wilding et al., NEJM 2021). Real-world compounded semaglutide outcomes appear similar based on provider reports, but no large-scale trials exist.
Why is compounded semaglutide so much cheaper than Ozempic? Compounded medications skip the brand-name distribution chain, marketing costs, and patent-protected pricing. A compounding pharmacy makes the medication in response to an individual prescription, reducing overhead. Brand-name Ozempic's price reflects Novo Nordisk's development costs, FDA approval process, and market positioning.
Can I use a GoodRx coupon to make brand-name GLP-1 cheaper? Yes. GoodRx coupons can reduce Ozempic's cash price from $1,100 to $835 to $920 depending on pharmacy and location. You cannot combine GoodRx with insurance, it's one or the other. GoodRx payments don't count toward your insurance deductible.
Do telehealth platforms accept insurance for compounded GLP-1? No. Compounded medications are not covered by insurance. Telehealth platforms sell compounded semaglutide and tirzepatide as cash-pay services. You pay out-of-pocket, and the cost doesn't count toward your deductible or out-of-pocket maximum.
What's the difference between 503A and 503B compounding pharmacies? 503A pharmacies compound medications in response to individual patient prescriptions. 503B outsourcing facilities compound larger batches under stricter FDA oversight. Both are legal and state-licensed. FormBlends works with 503B facilities, which follow current good manufacturing practices (cGMP) similar to commercial drug manufacturers.
How long does a vial of compounded semaglutide last? Most compounded semaglutide vials contain a 4-week supply at your prescribed dose. Some higher-concentration vials last 6 to 8 weeks. Vials must be refrigerated and used within 28 to 60 days after first puncture depending on formulation (check your pharmacy's specific guidance).
Is tirzepatide worth the extra cost over semaglutide? Tirzepatide produces 3 to 5 percentage points more weight loss on average compared to semaglutide in head-to-head trials (Jastreboff et al., NEJM 2022). For a 200-pound patient, that's 6 to 10 additional pounds over six months. If semaglutide at therapeutic dose produces inadequate response after 16+ weeks, tirzepatide is worth trying. Starting with tirzepatide from day one costs $100 to $200 more monthly without proven benefit for most patients.
Can I switch from brand-name Ozempic to compounded semaglutide mid-treatment? Yes. The active ingredient is the same. Your provider will convert your current Ozempic dose to the equivalent compounded dose. Most patients switch without interruption. The main adjustment is learning to draw from a vial instead of using a pen.
What happens if the FDA shortage ends and compounding is no longer allowed? The FDA allows compounding of semaglutide and tirzepatide only while they're on the drug shortage list. If removed from the shortage list, compounding pharmacies must stop production within a grace period (typically 60 to 90 days). Patients would need to transition to brand-name or discontinue. Most telehealth platforms communicate this risk upfront and help with transitions if needed.
Are there cheaper GLP-1 options coming in 2026 or 2027? Generic semaglutide won't be available until Novo Nordisk's patents expire (2031 to 2033 depending on jurisdiction). Oral semaglutide (Rybelsus) is available but costs similar to injectable Ozempic. The most likely price disruption is increased competition among compounding pharmacies, which could push prices below $150/month by late 2026.
Does FormBlends offer payment plans or financing? FormBlends pricing is month-to-month with no long-term contracts. You pay each month as you go. Some patients use HSA/FSA cards (compounded medications are eligible expenses). We don't offer internal financing, but third-party medical financing (CareCredit, etc.) can be used if your provider accepts it.
Sources
- Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
- Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine. 2022.
- Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. 2021.
- Novo Nordisk. Ozempic (semaglutide) Prescribing Information. 2024.
- Eli Lilly. Mounjaro (tirzepatide) Prescribing Information. 2024.
- GoodRx Research Team. Prior Authorization Survey: GLP-1 Medications. 2024.
- FDA Drug Shortages Database. Semaglutide and Tirzepatide Shortage Status. Accessed April 2026.
- Centers for Medicare & Medicaid Services. Medicare Part D Formulary Reference File. 2026.
- National Association of Boards of Pharmacy. Compounding Pharmacy Regulations: 503A vs 503B. 2025.
- Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
- Kadowaki T et al. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. The Lancet Diabetes & Endocrinology. 2022.
- Garvey WT et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022.
- U.S. Department of Health and Human Services. Federal Poverty Level Guidelines. 2026.
- American Society of Health-System Pharmacists. Compounding Standards and Regulations. 2025.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. Walmart, CVS, Walgreens, Costco, Sam's Club, and GoodRx are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.